Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial

1. Herbst, R.S.
2. Arkenau, H.-T.
3. Santana-Davila, R.
4. Calvo, E.
5. Paz-Ares, L.
6. Cassier, P.A.
7. Bendell, J.
8. Penel, N.
9. Krebs, M.G.
10. Martin-Liberal, J.
11. Isambert, N.
12. Soriano, A.
13. Wermke, M.
14. Cultrera, J.
15. Gao, L.
16. Widau, R.C.
17. Mi, G.
18. Jin, J.
19. Ferry, D.
20. Fuchs, C.S.
21. Petrylak, D.P.
22. Chau, I.